会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • NOVEL GENE SMS 44
    • EP2229450A1
    • 2010-09-22
    • EP09700851.0
    • 2009-01-09
    • DSM IP Assets B.V.
    • CHEVREUX, BastienMOUNCEY, Nigel John
    • C12P17/04C12P7/60C12N9/12C12N15/00
    • C12N9/1223C12P7/60C12P17/04
    • The present invention relates to novel genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C) and/or 2-keto-L- gulonic acid (hereinafter also referred to as 2-KGA). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to modified proteins and polynucleotides encoding said modified proteins as well as to modified microorganisms, wherein the modification has a direct or indirect impact on yield, production, and/or efficiency of production of Vitamin C and/or 2-KGA in said microorganisms. Also included are processes of using the modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C and/or 2- KGA.
    • 本发明涉及编码参与L-抗坏血酸(以下也称为维生素C)和/或2-酮-L-古洛糖酸(以下也称为2-KGA)合成的蛋白质的新基因 )。 本发明的特征还在于包含新基因及其片段的全长多核苷酸序列的多核苷酸,由该多核苷酸及其片段编码的新多肽以及它们的功能等价物。 本发明还涉及编码所述修饰蛋白的修饰蛋白和多核苷酸以及修饰的微生物,其中所述修饰对维生素C和/或2-KGA产生,产生和/或产生效率具有直接或间接影响 在所述微生物中。 还包括使用修饰的多核苷酸序列转化宿主微生物的过程。 本发明还涉及基因工程微生物及其用于直接生产维生素C和/或2-KGA的用途。
    • 2. 发明公开
    • Methods for the production of products in host cells
    • 在Wirtszellen的Verfahren zur Herstellung von Produkten
    • EP2039774A1
    • 2009-03-25
    • EP08015715.9
    • 2002-04-04
    • Genencor International, Inc.
    • Dodge, Timothy, C.Valle, Fernando
    • C12P1/00C12P7/00C12P7/40C12P7/58C12P7/60C12N9/00C12N9/10C12N9/12C12N1/20C07H21/04
    • C12N15/52C12P7/46C12P7/60C12P19/02
    • The invention provides methods and host cells for the production of ascorbic acid intermediates. The invention also provides host cells having a modification in a polynucleotide that uncouples the catabolic pathway from the oxidative pathway by deleting the encoding for an endogenous enzymatic activity that phosphorylates D-glucose at its 6 th carbon and/or a polynucleotide that has deleted the encoding for endogenous enzymatic activity that phosphorylates D-gluconate at its 6 th carbon. Such host cells are used for the production of products, such as, ascorbic acid intermediates. Nucleic acid and amino acid sequences with inactivated enzymatic activity which phosphorylates D-glucose at its 6 th carbon and inactivated enzymatic activity which phosphorylates D-gluconate at its 6 th carbon are provided.
    • 本发明提供了用于生产抗坏血酸中间体的方法和宿主细胞。 本发明还提供了在多核苷酸中具有修饰的宿主细胞,其通过缺失在其第6个碳上磷酸化D-葡萄糖的内源性酶活性和/或已经缺失编码的多核苷酸的编码来解离分解代谢途径从氧化途径 用于在其第6个碳上磷酸化D-葡萄糖酸盐的内源酶活性。 这种宿主细胞用于生产产品,如抗坏血酸中间体。 提供了具有灭活的酶活性的核酸和氨基酸序列,其在其第6碳上磷酸化D-葡萄糖,并且在其第6个碳上磷酸化D-葡萄糖酸盐的失活的酶活性。